• Increase font size
  • Default font size
  • Decrease font size
Information for citizens
Information for medical specialists
Information for companies

We inform you that in connection with the forthcoming promulgation of the Ordinance amending Ordinance No. 27/15.06.2007, on the web site of BDA are published the approved forms of applications for marketing authorization of medicinal product, renewal of marketing authorization, marketing authorization/registration of homeopathic medicinal product, variation to marketing authorization/registry certificate of medicinal product, transfer of the rights over marketing authorization of medicinal product and modification of the product information (the text and/or the package layout and/or leaflet, which is not connected with change of the short product characteristics) (There is no concomitant variation procedure).

The applications should be applied from the date of entry into force of the Ordinace amending Ordinance No. 27/15.06.2007.

 

European Medicines Agency concludes class review of bisphosphonates and atypical fractures

Benefit-risk review of Multaq started

European Medicines Agency recommends use of fibrates as second-line treatment

 

The Bulgarian Drug Agency informs the marketing authorization holders that in the cases of submission of group of variations to marketing authorization/s under the order of REGULATION (EC) No.1234/2008, the relevant taxes, specified in the Tariff of fees, collected under LMPHM, are paid for each single change in the group.

 
INTEGRATED MANAGEMENT SYSTEM
INTEGRATED MANAGEMENT SYSTEM :: MOODY INTERNATIONAL CERTIFICATION EN ISO 9001:2008 INTEGRATED MANAGEMENT SYSTEM :: MOODY INTERNATIONAL CERTIFICATION BS ISO/IEC 27001:2005
Please, click the logo above to see all the certificates.
Top